At a glance
ClinicalIndex Comparison RecordN/ACompleted· 134 enrolled
Drug / intervention
Stenting of the Common and/or External Iliac Arteriesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
In Brief
A clinical study evaluating Stenting of the Common and/or External Iliac Arteries for Peripheral Arterial Disease. Completed, enrolled 134 participants across 27 sites in 2 countries.
Detailed Summary
Evaluation of the Gore(R) VIABAHN BX for the treatment of arterial occlusive disease in the common and/or external iliac arteries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
CountriesNew Zealand, United States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 2014
Enrollment StartJul 2014
Primary CompletionMay 2016
Study CompletionOct 2018
TodayJul 2026
First PostedMar 6, 2014
Enrollment StartJul 1, 2014
Primary CompletionMay 1, 2016
Study CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 12.3 years ago
Interventions
Stenting of the Common and/or External Iliac Arteriesdevice
Balloon expandable stenting of iliac occlusive disease.